Pharmaceuticals Remote care Telehealth 
Healthcare IT News - Telehealth
AUGUST 9, 2021
"These new care from anywhere innovations ensure that we continue this digital transformation in healthcare and empower providers, payers, care coordinators and pharmaceutical companies to deliver care for patients wherever they are," he added. Vivify Health's remote care enhancements.
Healthcare IT News - Telehealth
MAY 29, 2024
Healthcare providers in Australia have been "slow" in their uptake of remote care technologies, such as remote patient monitoring and digital therapeutics. Practitioners are also unlikely to recommend remote care due to dearth of reimbursement incentives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT News - Telehealth
MAY 6, 2020
The CAM Patch can serve as a remote patient monitoring system during the COVID-19 pandemic, the vendor said. Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies.
Healthcare IT News - Telehealth
AUGUST 19, 2024
We interviewed Nissim to discuss diabetes treatment challenges, how RPM can help overcome some of these challenges, how AI can boost RPM technology when dealing with chronic illnesses, how adequately addressing diabetes can save taxpayers money, and what Nissim calls "the next generation of remote care."
care innovations
JANUARY 2, 2019
2018 was a historic year for telehealth and remote patient monitoring (RPM), as a series of developments played out that helped extend these important care delivery services to more patients than ever before. January: Unbundled CMS Code Increases Remote Care Reimbursement. Get more details here. January 18, 2018.
Lloyd Price
NOVEMBER 25, 2023
This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.
Lloyd Price
FEBRUARY 18, 2024
Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations.
Expert insights. Personalized for you.
155 
Let's personalize your content